Fonte: Journal of Heart and Lung Transplantation. Nome do evento: International Society for Heart and Lung Transplantation Annual Meeting - ISHLT. Unidade: IFSC
Assuntos: TRANSPLANTE DE PULMÃO, TERAPIA FOTODINÂMICA, HEPATITE C
ABNT
CYPEL, M. et al. A clinical trial evaluating the effects of ultra-violet C treatment (UVC) during ex vivo lung perfusion (EVLP) as a method of inactivating hepatitis C infection in donor lungs. Journal of Heart and Lung Transplantation. Philadelphia: Elsevier. Disponível em: https://doi.org/10.1016/j.healun.2019.01.117. Acesso em: 14 nov. 2024. , 2019APA
Cypel, M., Galasso, M., Ribeiro, R., Wilson, B., Bagnato, V. S., Kurachi, C., et al. (2019). A clinical trial evaluating the effects of ultra-violet C treatment (UVC) during ex vivo lung perfusion (EVLP) as a method of inactivating hepatitis C infection in donor lungs. Journal of Heart and Lung Transplantation. Philadelphia: Elsevier. doi:10.1016/j.healun.2019.01.117NLM
Cypel M, Galasso M, Ribeiro R, Wilson B, Bagnato VS, Kurachi C, Chen M, Kumar D, Waddell TK, Singer LG, Keshavjee S, Humar A, Feld J. A clinical trial evaluating the effects of ultra-violet C treatment (UVC) during ex vivo lung perfusion (EVLP) as a method of inactivating hepatitis C infection in donor lungs [Internet]. Journal of Heart and Lung Transplantation. 2019 ; 38( 4): S53-S54.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.healun.2019.01.117Vancouver
Cypel M, Galasso M, Ribeiro R, Wilson B, Bagnato VS, Kurachi C, Chen M, Kumar D, Waddell TK, Singer LG, Keshavjee S, Humar A, Feld J. A clinical trial evaluating the effects of ultra-violet C treatment (UVC) during ex vivo lung perfusion (EVLP) as a method of inactivating hepatitis C infection in donor lungs [Internet]. Journal of Heart and Lung Transplantation. 2019 ; 38( 4): S53-S54.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.healun.2019.01.117